Bibliographic information
GuidelineUpdated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year of Publication2018
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
A raltegravir (RAL)-based regimen is recommended as the preferred first-line regimen for neonates
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO